Basic Information
(1) Work Experience, Professional Background, and Concurrent Positions
I was born in October 1970 and graduated with a doctoral degree from the School of Management at Zhejiang University in 2001. I have served as the Vice Dean of the School of Management at Xi'an Jiaotong University (on secondment), Dean of the School of Economics and Management at Xinjiang University, and Director of the Economic Research Institute and Population Research Institute. I am currently a second-level professor and doctoral supervisor at Xinjiang University, Secretary-General of the Xinjiang Economic Society, and a director of the China Management Science and Engineering Society. I have been an independent director of Hengsheng Medical Technology Co., Ltd. since June 2025. I meet the qualifications for independent directors as stipulated by relevant laws and regulations, and my qualifications have been filed and reviewed by the Shenzhen Stock Exchange.
(2) No Factors Affecting Independence
I do not hold any position other than that of independent director at Tian Shun Co., Ltd. (hereinafter referred to as "the Company" or "Tian Shun"), and I have no direct or indirect interests with the Company or its major shareholders that could affect my independent judgment. I have independently fulfilled my duties without influence from the Company or its major shareholders. In 2025, I conducted a self-assessment of my independence and confirmed compliance with applicable regulatory requirements for serving as an independent director of Tian Shun. The board evaluated my independence and found no factors affecting my ability to make independent and objective judgments, affirming that I meet the independence requirements for the role.
Annual Performance
(1) Attendance at Meetings
I dedicated sufficient time to fulfill my responsibilities. In 2025, I personally attended all required board and committee meetings, participating in board decisions and expressing clear opinions on discussed matters. I did not miss two consecutive meetings or delegate attendance to other independent directors.
- Attendance at Board and Shareholder Meetings
During 2025, the sixth board of directors held 8 board meetings and 2 shareholder meetings, all of which I attended in person. I believe that the convening and conducting of board meetings and shareholder meetings, as well as major operational decisions and other significant matters, complied with legal procedures and were valid. I voted in favor of all proposals reviewed during the reporting period, with no instances of opposition or abstention.
| Board Meeting Attendance | Shareholder Meeting Attendance |
|---|---|
| Required Attendance | In-Person Attendance |
| 8 | 8 |
| Delegated Attendance | Absences |
| 0 | 0 |
| Consecutive Absences | Meeting Frequency |
| 0 | 2 |
-
Attendance at Board Committees
In 2025, the sixth Compensation and Assessment Committee, Strategic Committee, and Audit Committee held 8 meetings. As the Chair of the Compensation and Assessment Committee and the Strategic Committee, and a member of the Audit Committee, I attended all 8 meetings in person, with no instances of delegation or absence. I strictly adhered to the relevant requirements of the board committee's working rules, actively fulfilling my responsibilities as a member, maintaining positive communication with management, and providing professional suggestions and independent opinions regarding the formulation and execution of the Company's compensation and performance assessment systems. -
Attendance at Independent Director Meetings
In 2025, independent director meetings were held 3 times, and I attended all 3 meetings on time. We reviewed and approved proposals regarding related party transactions, increased daily related party transactions, deregistering subsidiaries, and changing accounting firms. I diligently fulfilled my responsibilities and obligations as an independent director, providing independent judgments on these matters to facilitate effective discussions and prudent decision-making by the board.